Riktkurs.nu
EN | SV
VNV GlobalMid Cap
Stockholm Stock Exchange | Mid Cap
Xvivo Perfusion
+15.33%
Latest
+8.91%
3 months
SEBPareto SecuritiesDanske Bank MarketsDNB MarketsSEB EquitiesCarnegieDNBBryan GarnierDanske Bank

Price Targets For Xvivo Perfusion

AnalystPrice TargetDateUpside
SEB425 SEKApr 25
+15.33%
Pareto Securities420 SEKApr 25
Danske Bank Markets405 SEKApr 15
DNB Markets418 SEKJan 29
SEB Equities390 SEKJan 26
Carnegie350 SEKJan 26
DNB452 SEKJan 17
Bryan Garnier340 SEKNov -23
Danske Bank403 SEKOct -22

About The Company

XVIVO is a medical technology company firmly rooted within medical science with more than 20 years of experience in the transplantation area.
Xvivo Perfusion

The information on Riktkurs.nu is for general information purposes only. Riktkurs.nu makes no guarantees of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to Riktkurs.nu or the information, products, services, or related information on Riktkurs.nu for any purpose. The recipient is recommended to complete his or her decision basis with the material deemed necessary. We reserve us for all types of errors as well as any malfunctions of the website. The information on Riktkurs.nu should not be seen as a recommendation to buy or sell a security.
© Riktkurs.nu 2024
Updated 4/25/2024 10:37:07 AM